Registered entities
Eiger Biopharmaceuticals, Inc.
Reg. No. 1305253United States
Investor mix
15 investors on record; lead investors include Pfizer, Novartis, GBS, Johnson & Johnson Innovation – JJDC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 4 | 27% |
| Other / undisclosed | 3 | 20% |